Bryce Joanne 4
4 · Disc Medicine, Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Bryce Joanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-10+27,250→ 27,250 totalExercise: $63.90Exp: 2034-01-09→ Common Stock (27,250 underlying) - Award
Common Stock
2024-01-10+18,165→ 23,665 total
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.